Overview

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Status:
NOT_YET_RECRUITING
Trial end date:
2035-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.
Phase:
PHASE4
Details
Lead Sponsor:
Jay C. Buckey Jr.
Collaborator:
Dartmouth College
Treatments:
Oxygen